Ro 0437626

Names

[ Name ]:
Ro 0437626

[Synonym ]:
Cortistatin 14

Biological Activity

[Description]:

Ro 0437626 is a selective purinergic (P2X1) receptor antagonist (IC50 = 3 μM), but shows low affinity for P2X2, P2X3 and P2X2/3 receptors (IC50 > 100 μM)[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Membrane Transporter/Ion Channel >> P2X Receptor

[Target]

IC50: 3 μM (P2X1 receptor)

[In Vitro]

Ro 0437626 reduces PMA-evoked Ca2+entry with 6.8 ± 4.7% of control[2].

[In Vivo]

Ro 0437626 (1 and 10 μmol/kg; i.v.) causes a reduction in postinfusion isovolumetric contractions[3]. Animal Model: Female rat (urethane-anaesthetized)[3] Dosage: 1 and 10 μmol/kg Administration: I.v. Result: Caused a reduction in postinfusion isovolumetric contractions.

[References]

[1]. Jaime-Figueroa S, et al. Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist. Bioorg Med Chem Lett. 2005;15(13):3292-3295.

[2]. Harper MT, et al. Phorbol ester-evoked Ca2+ signaling in human platelets is via autocrine activation of P(2X1) receptors, not a novel non-capacitative Ca2+ entry. J Thromb Haemost. 2010;8(7):1604-1613.

[3]. King BF, et al. Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats. Br J Pharmacol. 2004;142(3):519-530.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₇H₃₅N₅O₄S

[ Molecular Weight ]:
525.66300

[ Exact Mass ]:
525.24100

[ PSA ]:
168.47000

[ LogP ]:
3.72930

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.